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A B S T R A C T
The purpose of this paper is to show the importance of gastric mucosa imprint cytology in detecting stomach cancer.
Analyzed were 364 cytological and pathohistiological samples taken from 335 patients having suspected diagnosis of
gastric cancer. Every specimen was submitted to slide imprinting and then fixed in formalin for further processing with
routine histopathology. The imprints were air dried for cytological analysis, stained according to May-Grünwald-Giem-
sa and analyzed by light microscope.
By pathohistological punch-biopsy samples analysis stomach cancer was found in 45 samples. With cytologycal sam-
ples analysis the cancer was detected in 48 samples and 13 cytological samples were suspected of cancer. With combining
these two methods cancer was found in 68 cases. Patients with positive cytological finding and negative pathohistologic
finding underwent gastroscopy with punch-biopsy. All patients with positive patohistological findings were operated. All
materials were histologically examined. Cancer was found in 68 patients. Cytological analysis of stomach mucosa bio-
ptic material imprints, increases the number of positive findings in preoperative stage of gastric cancer diagnosis. The
greatest advantage of this method is short period for preparation of material, simplicity and low price. Every data on
morphological changes in mucosa has been also pathohistologically checked, because taking imprints does not damage
the specimen.
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Introduction
As in most malignant diseases gastric cancer progno-
sis and survival with other factors mostly depend on per-
centage of spreading when the disease was diagnosed,
therefore early detection of disease is of greatest impor-
tance. Japanese authors were first to observe and de-
scribe the early cancer (T1N0M0), depending on depth of
stomach infiltration, metastasis in lymph nodes or dis-
tant organs1. It was proved that such patients have sig-
nificantly better prognosis and that 95% of them lived
another 5 years2. In eighties 2.8–4.2% of patients in
TIN0M0 stage of disease in Europe and USA were trea-
ted while in Japan 66% of operated patients were in
T1N0M0 stage of disease. The reason for these good re-
sults was implementation of esophagogastroduodenosco-
py with possibility of taking specimens for cytology and
histology with screening of endangered population3,4.
As far as other body sites, are concerned the examina-
tion of exfliative cytologic specimens that were taken
from gastrointestinal tract was not used for number of
years. Mostly, it was because of lack of satisfactory pro-
cesses for collecting sufficient number of well-preserved
cells from these digestive organs5. In 1947 Papanicolau
and Cooper reported a gastric lavage method for collect-
ing cells from the stomach. Later, Papanicolau and col-
leagues introduced a blind abrasive gastric balloon5. How-
ever, the present diagnostic era arrived with develop-
ment and more widespread usage of flexible fiberoptic
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endoscopes for upper gastrointestinal tract, coupled with
visually directed samplings of lesions2,6,7,8.
This study reviewes the reliability and efficiency of
the cytodiagnosis of imprint cytology of gastric mucosa
biopsy obtained under direct vision, during esophago-
gastroduodenoscopy in 335 patients. The purpose was to
evaluate role of cytology in establishing the diagnosis of
gastric cancer.
Materials and Methods
During five-year period, to be exact from January 1,
1997 to December 31, 2001, 364 punch biopsy samples
were taken from 335 patients that had clinical or endo-
scopic suspicion on gastric cancer. 75 patients were oper-
ated because they had cytological and/or histological gas-
tric cancer diagnosis. All materials were completely his-
tologically examined. Gastric cancer was found in 68 op-
erated patients. Four operated patients had gastric pol-
yps, two had peptic ulcers, and one was operated because
was suspected of early gastric cancer although no cyto-
logical or pathological finding cancer. In 289 patients gas-
tric carcinoma was not detected. Although they were
monitored for number of years. In patients with preoper-
ative positive cytological and negative pathohistological
findings endoscopic examination was repeated and in
335 patients specimens for cytological and pathohisto-
logical analysis were taken 364 times. For final compari-
son of methods, excluded were the cancer patients who at
the time of diagnosis were inoperable, patients that did
not have cytological samples, patients that have been op-
erated as urgent cases without prior preoperative mor-
phologic diagnosis and patients operated in other institu-
tions, for whom pathohistological finding could not be
obtained.
In gastric biopsy, 1–3 samples to were analyzed per
patient. Each specimen was firstly submitted to slide im-
printing and then formalin fixed for routine histopatho-
logy. Imprints were air dried, stained by May Grünwald-
-Giemsa method (MGG) and analyzed by a light micro-
scope. Then the specimens were fixed in 10% buffered
formalin, paraffin embedded, cut into 5 mm sections,
stained with hemalaun-eosin (HE) and analyzed by a
light microscope9,10.
Based on cytological diagnostic criteria for gastric
cancer, the cytological specimens were classified in 3 cat-
egories: positive, suspicious and negative. For this study,
the findings of cytology and histology on the biopsy sam-
ple, the postoperative diagnosis (including histopatho-
logy) and the follow-up were compared for each of the
335 cases with definitive diagnosis. Based on final diag-
nosis, the cytological and histological diagnosis of the bi-
opsy sample in each case were categorized as true posi-
tive (TP, including positive and suspicious diagnoses),
true negative (TN, including negative and unsatisfactory
findings), false negative (FN) and false positive (FP)11.
Collected data were statistically evaluated with me-
thod of Galen and Gambino. The following standard for-
mulae were used: sensitivity = TP/(TP+FN)x100; speci-
ficity = TN/(TN+FP)x100; false positive rate (FP) =
FP/(FP+TN)x100; false negative rate (FN) = FN/(FN+
TP)x100; PV of a positive result = TP/(TP+FP)x100; PV
of a negative result = TN/(TN+FN)x100; prevalence
rate = (TP+FN)/(TP+TN+FP+FN)x10011. The overall
diagnostic accuracy is the probability of the patients be-
ing correctly identified as true positive and true negative
by the cytological test.
Results
In the period of five years, 364 fiber-endoscopic biop-
sies were done in 335 patients because of suspicion on
stomach cancer. Malignant cells were found in 61 cyto-
logical samples. Cancer diagnosis was made in 45 his-
tological samples. 75 patients were operated because of
cytological and/or pathohistological (punch biopsy) can-
cer diagnosis. All materials were completely histologi-
cally examined. Stomach cancer was found in 68 oper-
ated patients. Excluded were patients with malignant
diseases who at the time of diagnosis were inoperable,
patients from whom cytological sample was not taken,
patients that were urgently operated without preopera-
Lj. Fu{tar-Preradovi} et al.: Cytology in the Diagnosis of Gastric Cancer, Coll. Antropol. 34 (2010) 2: 355–358
356
TABLE 1
STATISTICAL ANALYSIS OF THE DATE
Cytology Punch byopsy Combined Operative Hystology
True positives 61 45 68 68
True negatives 289 289 289 0
False positives 2 0 2 0
False negatives 12 30.00 5 0
Sensitivity (%) 83.56 60.00 93.15 0
Specificity (%) 99.31 100.00 99.33
False positive rate (%) 0.69 0 0.67
False negative rate (%) 16.44 40.00 6.84
PV of a positive result (%) 96.83 100.00 93.15
PV of a negative result (%) 96.01 91.40 98.34
Prevalence rate (%) 20.05 19.03 19.68
tive morphologic diagnosis and patients operated in other
institutions, for which pathohistological findings could
not be obtained.
The cytological findings in 364 cytological samples
were positive in 48 (13.2%) cases, suspicious in 13 cases
(3.57%) and negative in 289 (79.4%). Compared to final
diagnosis (operative histology), there were 61 TP (89.7%),
289 TN, 12 FN and 2 FP cytological diagnoses. This gave
sensitivity of 83.56%, specificity of 99.31% FN rate of
16.44%, FP rate of 0.69%, and PV of a positive result of
96.83%, PV of a negative result of 96.01% and prevalence
rate of 20.05%. If we combine endoscopic cytology and
histology, sensitivity increases to 93.15%, and decreases
the false negative rate to 6.84% (Table 1).
Twelve FN cases included 12 cases of adenocarcinoma
(8 reported as chronic gastritis, 1 as gastric polyp and 3
as peptic ulcers). 2 false positive cases included 1 peptic
ulcer and 1 gastric polyp. While FN results were due to
various factors, including method of taking material,
number of taken samples, place where samples were
taken and misinterpretation. All of FP results were due
to misinterpretation.
Discussion and Conclusion
Number of described tumours in this paper does not
represent absolute number of checked and operated pa-
tients in our hospital. We considered the patients who
had esophagogastroduodenoscopy, punch-biopsy, cytolog-
ical samples and hystologycal samples and well-known fi-
nal diagnosis (operative histology or clinical monitoring).
Some of the patients were operated and further treated
in other institutions, some were inoperable at the time of
setting diagnosis, and some of them were operated ur-
gently, without making prior endoscopic and/or cytolo-
gycal and pathohistological diagnosis. For patients with
positive cytological findings and negative pathohisto-
logical findings examination was repeated immediately
or in intervals of one to three months, and after that they
were monitored for at least one year.
Nowadays, brush specimens is mostly frequently used
method of taking material for cytology12,13. The same
method was also used in our institution when the exami-
nation was introduced. Material was directly placed from
the brush to the slides. As we were not satisfied with
quantity and quality of material and results we switched
to imprint method. Kathleen14 describes that washing
endoscope canal gives 91% positive results. Crisoula15
says that imprint method gives 94.4% positive find-
ings. Our result of 89.71% positive samples on five year
material obtained by imprint method coincide literature
(78–94.4%)16–20.
Sensitivity of 83.56% satisfies, particularly because
the number of false positive diagnoses was kept to a min-
imum (specificity 99.31%). This sensitivity is similar to
the ones reported by other centres. The cytological exam-
ination gave false positive results in 2 samples (0.69%),
for which biopsies were negative. Sensitivity in tracked
period for punch biopsy histology was 60%, and with
combining two methods increased to 93.15%. The num-
ber of false negative cytologycal samples is 12 (3.3%) and
false negative histological samples 30 (8.24%). Combi-
ning two methods number of false negative samples was
reduced to 5 (1.37%). For false negative samples beside
other factors important is the number of taken samples.
Increasing the number of samples, taken from multiple
locations increases the number of positive cytological
and pathohistological findings (with some authors even
above 90%), what opens the question of simultaneous
taking cytological samples.
Great numbers of authors recommend using both
methods because it increases the percentage of preopera-
tively exactly made diagnoses. Cusso states that both
methods should be used, because using cytology only in
selected cases can give poor results and therefore dis-
courage doctors to use it16. In our case, where neither
method had sensitivity over 90%, and when using the
two methods sensitivity raised to 93.15%, significance of
using two methods is not questionable. Besides, gastric
mucosa imprint cytology is fast, simple and cheap me-
thod for detecting stomach cancer, and characterized
with high sensitivity and specificity as compared with
histopathology.
We might conclude that usage of esophagogastro-
duodenoscopy with cytology and histology increases the
number of preoperatively made diagnoses, but does not
increase the number of patients that were detected in
T1N0M0 stage of diseases. The increase in number of di-
agnosed patients can be achieved only by screening of en-
dangered population.
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USPOREDNA ANALIZA HISTOLO[KIH NALAZA I CITOLO[KIH NALAZA OTISKA BIOPSIJE
@ELUCA U DIJAGNOZI KARCINOMA @ELUCA
S A @ E T A K
Cilj ovoga rada bio je ustanoviti vrijednost citolo{ke analize otiska ekscidirane sluznice `eluca u otkrivanju kar-
cinoma `eluca. Analizirano je 364 bioptata kod 355 bolesnika kod kojih je endoskopskim pregledom postavljena sumnja
na karcinom `eluca. Od svakog uzorka najprije je na~injen preparat otiska na staklo, a zatim je uzorak fiksiran u
formalinu za daljnju rutinsku patohistolo{ku obradu. Preparat je za citolo{ku analizu osu{en na zraku, bojan metodom
po May-Grünvald-Giemsi i analiziran svjetlosnim mikroskopom. Patohistolo{kom analizom karcinom `eluca na|en je u
46 uzoraka, a citolo{ki u 48 uzoraka, dok je 13 citolo{kih uzoraka bilo suspektno na karcinom `eluca. Kombiniraju}i ove
dvije metode na|en je karcinom u 68 uzoraka. Bolesnicima koji su imali pozitivan citolo{ki nalaz, a negativan pato-
histolo{ki nalaz ponovljena je ezofagogastroduodenoskopijaskopija sa biopsijom. Svi bolesnici sa pozitivnim nalazom su
operirani i dobiveni materijal je u cijelosti patohistolo{ki pregledan. Karcinom je na|en kod 68 bolesnika. Citolo{ka
analiza preparata otiska biopti~kog materijala sluznice `eluca pove}ava postotak pozitivnih nalaza u preoperativnoj
dijagnozi karcinoma `eluca. Najve}a prednost metode je brzina, jednostavnost i niska cijena. Svaki podatak o mor-
folo{kim promjenama sluznice provjerava se i patohistolo{ki jer uzimanje otiska ne o{te}uje uzorak.
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